Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 9/20 | 0.41 |
| ▸ | CA2 | P00918 | 9/20 | 0.41 |
| ▸ | CA12 | O43570 | 6/20 | 0.41 |
| ▸ | CA9 | Q16790 | 6/20 | 0.41 |
| ▸ | STK17B | O94768 | 1/20 | 0.38 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5919555 | 0.95 | CA14 (0.58) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL19340291 | 0.93 | CA14 (0.57) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL25219848 | 0.92 | CA14 (0.62) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL3472122 | 0.92 | CA14 (0.62) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL7264039 | 0.92 | CA14 (0.58) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL7270004 | 0.92 | CA14 (0.58) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL1919913 | 0.91 | CA14 (0.60) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL9885950 | 0.91 | CA14 (0.63) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL4370840 | 0.91 | CA14 (0.59) | CA14MAOAMAOBTDP1MEN1 | |
| SCHEMBL7631999 | 0.89 | CA14 (0.62) | CA14MAOAMAOBTDP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170231228-A1 | SURFACE TREATMENTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2017-08-17 | — | — | US | disclosed |
| WO-2016185331-A1 | SURFACE TREATMENTS | BOVIN NICOLAI VLADIMIROVICH (RU) | 2016-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231228-A1 | SURFACE TREATMENTS | PHOSPHO1, SGMS2, SGMS1 | CA14 3800/4885MAOA 2421/4885MAOB 2764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.